XML 71 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements - Reconciliation of Level 3 Liabilities (Details) - Measured on a recurring basis - Level 3 - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2017
Oct. 01, 2016
Sep. 30, 2017
Oct. 01, 2016
Jul. 01, 2017
Dec. 31, 2016
Jul. 02, 2016
Dec. 31, 2015
Contingent consideration                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases $ 0.0 $ 30.6 $ 0.0 $ 61.1        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Gain (Loss) Included in Other Comprehensive Income (Loss) 0.2 0.0 1.5 0.1        
Contingent Consideration                
Contingent Consideration 44.9 75.0 44.9 75.0 $ 49.7 $ 69.9 $ 44.9 $ 17.9
Net realized losses (2.9) (0.4) (18.5) (4.0)        
Settlements (2.1) $ (0.1) (8.0) $ (0.1)        
Accounts Receivable [Member]                
Royalty Pharma Contingent Milestone Payments                
Royalty Pharma contingent milestone payments 143.2   143.2   $ 145.8 $ 0.0    
Additions $ 0.0   $ 184.5          
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset and Liability, Gain (Loss) Included in Other Comprehensive Income (Loss), Description 0.3   0.8          
Change in fair value $ (2.9)   $ (42.1)